PubMed=23498809; DOI=10.1016/j.transproceed.2012.09.121
Hu X., Yang T., Li C., Zhang L., Li M., Huang W., Zhou P.
Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model.
Transplant. Proc. 45:695-700(2013)

PubMed=23505090; DOI=10.1002/hep.26402
Wang K., Lim H.Y., Shi S., Lee J., Deng S., Xie T., Zhu Z., Wang Y., Pocalyko D., Yang W.J., Rejto P.A., Mao M., Park C.-K., Xu J.
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Hepatology 58:706-717(2013)

PubMed=26116706; DOI=10.1096/fj.14-266718
Ye F., Chen C.-G., Qin J., Liu J., Zheng C.-Y.
Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China.
FASEB J. 29:4268-4272(2015)

PubMed=26143199; DOI=10.1016/j.jhazmat.2015.06.031
Cui R., Zhang H.-X., Guo X.-J., Cui Q.-Q., Wang J.-S., Dai J.-Y.
Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ.
J. Hazard. Mater. 299:361-370(2015)

PubMed=27027780; DOI=10.1007/s10565-016-9316-2
Wu Y., Geng X.-C., Wang J.-F., Miao Y.-F., Lu Y.-L., Li B.
The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury.
Cell Biol. Toxicol. 32:37-59(2016)